2023-08-08 11:45:00
Specific therapy options in the USA
In the USA, two drugs are now specifically approved for the indication “postpartum depression in adults”. One of them, Zuranolone (trade name ZurzuvaeTM), was approved just last week. Like the brexanolone (trade name ZulressoTM), which was approved in 2019, the derivative of the neurosteroid allopregnanolone, zuranolone, is said to act via its function as a positive, allosteric modulator on the GABAA receptor. Such modulators facilitate binding of the natural ligand GABA and thus receptor activation. According to US technical information, the mechanism of action has not yet been fully clarified [3, 4].
1691499200
#Zuranolone #oral #therapy #option #postpartum #depression #receives #approval
Related posts:
Keratin Hair Treatment: Benefits and Risks
Javier Hernandez: From Chivas to Manchester United - A Journey with Cristiano Ronaldo and Real Madri...
"Eternal" plasmonic paint reduces consumption by 300 times compared to conventional paint
Institute for Natural Health Protection Ivermectin, the endless debate (and for good reason!)
Almost 70,000 fans at the open-air spectacle! – Hockey-News.info
Ronald Acuña Jr. will be a father for the second time | Sports Gossip 123
Fayoum Health Directorate Leads Training for Nurses on Women's Health and Chronic Disease Detection
Lose Belly Fat with These Top Diet Tips Featuring Green Vegetables, Lean Proteins, Whole Grains, and...